Login / Signup
[Prognostic Value of LMR and CD163 + TAM for Patients with Diffuse Large B Cell Lymphoma].
Xue Xu
Zong-Yuan Ye
Published in:
Zhongguo shi yan xue ye xue za zhi (2024)
TAM can be used as biological markers for poor prognosis of DLBCL patients.
Keyphrases
</>
diffuse large b cell lymphoma
poor prognosis
long non coding rna
epstein barr virus
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
patient reported outcomes
patient reported